Butchko Julia G.'s Form 4 filing
Immunovant, Inc. (IMVT) · filed Jan 11, 2022
- Accession no.
- 0001764013-22-000013
- Filed
- Jan 11, 2022
- Trade date
- Jan 7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $401.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butchko Julia G.CIK 0001796290 | Officer (Chief Dev. & Tech. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2022 | Common Stock | SSaleDisposed | −55,318 | $7.25 | −$401,055.5 | 289,488 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney